Cyclooxygenase-2 expression in lung cancer
Zhang Lin
Abstract
Zhang Lin
Abstract
OBJECTIVE:To explore the relationship between the expression of COX-2 and pathophysiological features of patients with lung cancer.METHODS:With method of immunohistochemistry, expression of COX-2 protein was detected in lung cancer tissues, corresponding normal paracancerous pulmonary tissues and 16 metastatic lymph nodes of 72 patients with lung cancer.RESULTS:COX-2 was positively expressed in 35 of 72 lung cancer tissues (48.6%), which was significantly higher than the rate,6.9% in paracancerous tissues,χ2=46.239, P=0.000. Patients exhibited much higher COX-2 expression in adenocarcinoma,71.9% than in squmouscarcinoma,42.8%,χ2=5.173,P=0.023, and no expression in the small-cell lung cancer group. No significant correlation was found among COX-2 expression level, patient age, smoking history, differentiation grade of tumor cells, TNM stage and lymph node metastasis,P0.05 (P=0.354,0.052,0.490,0.658,0.587,0.726).CONCLUSIONS:Increased expression of COX-2 may play an important role in the oncogenesis and development of non-small cell lung cancer.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE:To explore the relationship between the expression of COX-2 and pathophysiological features of patients with lung cancer.METHODS:With method of immunohistochemistry, expression of COX-2 protein was detected in lung cancer tissues, corresponding normal paracancerous pulmonary tissues and 16 metastatic lymph nodes of 72 patients with lung cancer.RESULTS:COX-2 was positively expressed in 35 of 72 lung cancer tissues (48.6%), which was significantly higher than the rate,6.9% in paracancerous tissues,χ2=46.239, P=0.000. Patients exhibited much higher COX-2 expression in adenocarcinoma,71.9% than in squmouscarcinoma,42.8%,χ2=5.173,P=0.023, and no expression in the small-cell lung cancer group. No significant correlation was found among COX-2 expression level, patient age, smoking history, differentiation grade of tumor cells, TNM stage and lymph node metastasis,P0.05 (P=0.354,0.052,0.490,0.658,0.587,0.726).CONCLUSIONS:Increased expression of COX-2 may play an important role in the oncogenesis and development of non-small cell lung cancer.
Key concepts: Lung cancer, Carcinogenesis, Adenocarcinoma, Medicine, Immunohistochemistry, Lung, Stage (stratigraphy), Pathology